A detailed history of Scientech Research LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Scientech Research LLC holds 59,023 shares of GH stock, worth $1.58 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
59,023
Holding current value
$1.58 Million
% of portfolio
0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.07 - $31.84 $948,499 - $1.88 Million
59,023 New
59,023 $1.7 Billion
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $221,540 - $302,847
10,266 New
10,266 $278 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.74B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Scientech Research LLC Portfolio

Follow Scientech Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scientech Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scientech Research LLC with notifications on news.